Study to Assess the Vaccine Efficacy Against Malaria Infection, in Children Immunized With the Primary and Yearly Booster of the RTS,S/AS01E Vaccine, as Part of Their Participation in the Malaria-094 (204889/NCT03276962) Study.
Clinical trial NCT03281291 · COMPLETED
Trial details
- NCT number
- NCT03281291
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2018-11-19
- Primary completion
- 2022-04-22
- Enrollment
- 1500
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.